Due to the low rate of aldosterone secretion, recent guidelines recommend the use of aldosterone/renin ratio to exclude primary aldosteronism only in patients with adrenal tumors and concomitant hypertension or unexplained hypokalemia [7]. This evidence concerns the gene REN and primary aldosteronism.